https://bioinformatics.umg.eu/onkopus/drugon#l01fmonoclonalantibodiesandantibodydrugconjugates
Properties
- label
- [] l01f monoclonal antibodies and antibody drug conjugates
Parents
Children
Relations
- is_atc
- rituximab
- is_atc
- nivolumab
- is_atc
- tislelizumab
- is_atc
- tafasitamab
- is_atc
- pertuzumab
- is_atc
- pembrolizumab
- is_atc
- ipilimumab
- is_atc
- dostarlimab
- is_atc
- polatuzumabvedotin
- is_atc
- inotuzumabozogamicin
- is_atc
- moxetumomabpasudotox
- is_atc
- avelumab
- is_atc
- durvalumab
- is_atc
- necitumumab
- is_atc
- trastuzumabemtansine
- is_atc
- amivantamab
- is_atc
- catumaxomab
- is_atc
- panitumumab
- is_atc
- atezolizumab
- is_atc
- daratumumab
- is_atc
- trastuzumabduocarmazine
- is_atc
- trastuzumab
- is_atc
- ramucirumab
- is_atc
- dinutuximab
- is_atc
- belantamabmafodotin
- is_atc
- blinatumomab
- is_atc
- bermekimab
- is_atc
- brentuximabvedotin
- is_atc
- prolgolimab
- is_atc
- edrecolomab
- is_atc
- elotuzumab
- is_atc
- oportuzumabmonatox
- is_atc
- olaratumab
- is_atc
- gemtuzumabozogamicin
- is_atc
- isatuximab
- is_atc
- bevacizumab
- is_atc
- enfortumabvedotin
- is_atc
- mogamulizumab
- is_atc
- obinutuzumab
- is_atc
- cetuximab
- is_atc
- sacituzumabgovitecan
- is_atc
- ofatumumab
- is_atc
- cemiplimab
- is_atc
- trastuzumabderuxtecan
- is_atc
- retifanlimab